Adipotide is a peptidomimetic chemical that has been found to have pro-apoptotic effects in rhesus monkeys and mice, and it has also been demonstrated to promote weight reduction in humans. It has the following sequence: CKGGRAKDC-GG-D(KLAKLAK)2. The preferential apoptosis of blood arteries that feed white adipose tissue has been demonstrated in studies to be the mechanism of action of this compound. Such vessels are affected by adipotide, which causes them to atrophy (shrinking) and finally apoptosis (cell death), therefore turning off the blood circulation to the fat cells. Ischemic damage occurs as a result of a lack of oxygenation to the adipose cells as a result of this. Because the effects are irreversible, the fat tissue also undergoes apoptosis, or cell death, in order to survive.

It has been demonstrated through molecular research that the stereochemical structure of Adipotide makes it possible for it to bind to two particular receptors that are only located in blood arteries that supply white adipose tissue to function. Prohibitin and ANXA-2 are the receptors involved. Adipotide has no effect on brown adipose tissue as a result of the tissue specificity of these receptors, and as a result, it has no influence on adaptive brown fat thermogenesis. Baby brown fat thermogenesis is extremely crucial since they have a restricted capability for heat conservation due to the high surface area to volume ratio of their bodies, which results in significant rates of heat loss. The formation of white adipose tissue occurs only when energy usage exceeds energy use in the body.


In 2008, epidemiological research revealed that obesity affects 33.9 percent of the entire adult population in the United States, according to the National Obesity Association. Obesity is caused by an increase in adipose tissue mass. Several studies have revealed that adipose tissue is the primary contributor to obesity. As previously stated, a rise in body mass does not always imply obesity because such an increase might be attributable to an increase in lean body mass rather than owing to an increase in adipose tissue. Obesity is related to an elevation in the rates of illness and death in the general population.

ADIPOCYTES (lipoprotein-storing adipocytes) and the vascular/stromal compartment, which contains macrophages and preadipocytes, are the two main components of adipose tissue. It is true that the hypertrophy of adipose cells as a result of increased lipid deposition, as well as the following hyperplasia of these cells, leads to a rise in body fat. It is expected that adipocytes inflicted with ischemic damage will become less differentiated and will undergo an increase in apoptotic activity. As a result, a peptidomimetic also including Adipotide would produce non-reversible ischemia damage to adipocytes situated in white adipose tissue, resulting in a decrease in adipose mass.


It is a peptidomimetic molecule with the sequence CKGGRAKDC-GG-D(KLAKLAK)2 that has pro-apoptotic and lipolytic characteristics, allowing it to be used as an anti-obesity peptide. Adipotide is a peptidomimetic substance with the sequence CKGGRAKDC-GG-D(KLAKLAK)2. The mechanism of action of this compound has been demonstrated to include specific apoptosis of the vasculature of white adipose tissue. Apoptosis occurs in the fat tissue cells as a result, and the total amount of adipose tissue is reduced. If you are a researcher, you can purchase Adipotide online and further study the benefits and downgrades of this peptide.